Organ-on-a-chip devices, also known as microphysiological systems, have gained significant attention in recent years. Recent advances in tissue engineering and microfabrication have enabled these devices to provide more precise control over cellular microenvironments to mimic the tissue-level or organ-level function of the human body. These more complex tissue models can provide either an improvement in the functional expression and maturation of cells or an avenue to probe biological events and function that would otherwise be difficult to visualize and mechanistically study. This high-value information, when complimented with the existing gold-standards of cell-based assays and animal models, could potentially lead to more informed decision-making in drug development. A prevalent biological component in many organ-on-a-chip devices is an engineered vascular interface that is present in almost all organs of the human body. The vasculature and the vascular interface are particularly susceptible to biomechanical forces, they function as the conduits for inter-cellular and inter-organ interactions, and regulate drug transport. In this review, we examine the various approaches taken to model the human vasculature with an emphasis on the engineering of organ-specific vasculatures, and discuss various challenges and opportunities ahead as the field advances.
12 July 2020 in ACS Biomaterials Science & Engineering
There is a growing demand for automated organ‐on‐a‐chip platforms that are compatible with off‐the‐shelf robotic liquid‐handling systems and plate readers to improve reproducibility and scalable analysis. In this work, we present an end‐to‐end automated method for fabricating tubular blood vessel models at scale using a custom 384‐well open‐top platform (AngioPlate384), designed to support integration with liquid‐handling systems and large‐scale analysis. Our approach enables the generation of over 100 perfusable blood vessels fully embedded in hydrogel and supported by stromal cells (fibroblasts and pericytes), allowing both luminal and interstitial flow. Using this platform, we demonstrated that stromal co‐culture significantly enhances vascular barrier function, and results in an altered response to chemotherapeutics and to inflammatory stressors. This platform offers a robust and scalable approach to generating customizable blood vessel‐on‐a‐chip models for vascular biology studies, disease modeling, and preclinical testing. Its compatibility with automation and standardized workflows positions it as a powerful tool to accelerate the adoption of microphysiological systems in pharmaceutical research.
1 October 2026 in Regulatory Toxicology and Pharmacology